SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-632137
Filing Date
2016-06-27
Accepted
2016-06-27 07:01:28
Documents
9
Effectiveness Date
2016-06-27

Document Format Files

Seq Description Document Type Size
1 S-8 d217383ds8.htm S-8 59994
2 EX-5.1 d217383dex51.htm EX-5.1 3945
3 EX-10.36 d217383dex1036.htm EX-10.36 129804
4 EX-10.37 d217383dex1037.htm EX-10.37 24343
5 EX-10.38 d217383dex1038.htm EX-10.38 22440
6 EX-10.39 d217383dex1039.htm EX-10.39 25266
7 EX-10.40 d217383dex1040.htm EX-10.40 33847
8 EX-10.41 d217383dex1041.htm EX-10.41 32136
9 EX-23.2 d217383dex232.htm EX-23.2 1823
  Complete submission text file 0001193125-16-632137.txt   334628
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-212255 | Film No.: 161732154
SIC: 2834 Pharmaceutical Preparations